Literature DB >> 32857960

Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane.

Jing-Ming Shi1, Li Zhu2, Xi Lan3, Duan-Wei Zhao4, Yong-Jun He1, Zheng-Qi Sun1, Di Wu2, Hai-Yun Li5.   

Abstract

Interactions between amyloid-β peptide (Aβ) and the cell membrane include interaction with membrane lipids and binding to membrane receptors, both of which are considered to be the toxicity mechanisms of Aβ. However, it is unclear whether both mechanisms lead to cytotoxicity. Thus, we aimed to analyze these two mechanisms of Aβ42 interaction with cell membranes under different Aβ aggregation states. To this end, model membrane experiments were conducted. Quantitative analysis of Aβ42 monomers or oligomers bound to the membrane of neuro-2a cells was also performed, and laser confocal microscopy was employed to assess endocytosis of FITC-Aβ42 monomers or oligomers by neuro-2a cells. We found that the binding capacity of Aβ42 to membrane lipids was weak and that the amount of Aβ42 bound to membrane lipids was low. Moreover, clathrin-mediated endocytosis of Aβ42 oligomers by neuro-2a cells was observed. Endocytosis serves as a key mode of interaction between extracellular Aβ42 and neurons. These findings provide insights into the mechanisms underlying Aβ oligomer metabolism.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32857960      PMCID: PMC7499104          DOI: 10.1016/j.bpj.2020.07.035

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  65 in total

Review 1.  The Cellular Phase of Alzheimer's Disease.

Authors:  Bart De Strooper; Eric Karran
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

2.  Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.

Authors:  Claudio Canale; Silvia Seghezza; Silvia Vilasi; Rita Carrotta; Donatella Bulone; Alberto Diaspro; Pier Luigi San Biagio; Silvia Dante
Journal:  Biophys Chem       Date:  2013-08-14       Impact factor: 2.352

3.  Amyloid ion channels: a common structural link for protein-misfolding disease.

Authors:  Arjan Quist; Ivo Doudevski; Hai Lin; Rushana Azimova; Douglas Ng; Blas Frangione; Bruce Kagan; Jorge Ghiso; Ratnesh Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

4.  Thioflavin T fluorescence to analyse amyloid formation kinetics: Measurement frequency as a factor explaining irreproducibility.

Authors:  Mathew Sebastiao; Noe Quittot; Steve Bourgault
Journal:  Anal Biochem       Date:  2017-06-13       Impact factor: 3.365

5.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

6.  Conformational transition of amyloid beta-peptide.

Authors:  Yechun Xu; Jianhua Shen; Xiaomin Luo; Weiliang Zhu; Kaixian Chen; Jianpeng Ma; Hualiang Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

7.  A vicious cycle of β amyloid-dependent neuronal hyperactivation.

Authors:  Benedikt Zott; Manuel M Simon; Wei Hong; Felix Unger; Hsing-Jung Chen-Engerer; Matthew P Frosch; Bert Sakmann; Dominic M Walsh; Arthur Konnerth
Journal:  Science       Date:  2019-08-09       Impact factor: 47.728

8.  Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy.

Authors:  Ricardo Capone; Felipe Garcia Quiroz; Panchika Prangkio; Inderjeet Saluja; Anna M Sauer; Mahealani R Bautista; Raymond S Turner; Jerry Yang; Michael Mayer
Journal:  Neurotox Res       Date:  2009-03-19       Impact factor: 3.911

9.  Model Phospholipid Liposomes to Study the β-Amyloid-Peptide-Induced Membrane Disruption.

Authors:  Wei Qiang; Katelynne E Doherty
Journal:  Methods Mol Biol       Date:  2018

Review 10.  Clinical trials of new drugs for Alzheimer disease.

Authors:  Li-Kai Huang; Shu-Ping Chao; Chaur-Jong Hu
Journal:  J Biomed Sci       Date:  2020-01-06       Impact factor: 8.410

View more
  1 in total

1.  Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.

Authors:  Zhe-Ao Zhang; Xin Xin; Chao Liu; Yan-Hong Liu; Hong-Xia Duan; Ling-Ling Qi; Ying-Ying Zhang; He-Ming Zhao; Li-Qing Chen; Ming-Ji Jin; Zhong-Gao Gao; Wei Huang
Journal:  J Nanobiotechnology       Date:  2021-12-28       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.